Genomma Lab Internacional, S.A.B. de C.V.
GNMLF
$1.43
$0.169913.48%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 67.21% | 728.30% | -116.05% | -7.89% | 23.12% |
| Total Depreciation and Amortization | -34.51% | 150.64% | -40.21% | 2.32% | -5.91% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.57% | 2.39% | 281.22% | 753.77% | -111.67% |
| Change in Net Operating Assets | 35.95% | -263.67% | 234.64% | 946.01% | 90.27% |
| Cash from Operations | 421.00% | -115.94% | 20.48% | 53.32% | 48.66% |
| Capital Expenditure | 65.50% | 26.62% | -24.71% | -14.79% | 38.02% |
| Sale of Property, Plant, and Equipment | 312.47% | -88.04% | 20,915.79% | -100.58% | 1,473.68% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -445.99% | 107.62% | -373.99% | 57.27% | 117.53% |
| Cash from Investing | -201.95% | 91.50% | -843.61% | 106.18% | 145.97% |
| Total Debt Issued | 257.56% | -40.06% | -10.30% | -72.07% | 732.41% |
| Total Debt Repaid | -297.99% | 57.04% | -24.11% | 73.92% | -394.12% |
| Issuance of Common Stock | -- | -- | 3,745.84% | -- | -- |
| Repurchase of Common Stock | -- | 97.79% | -- | -- | -111.64% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -6.91% | -2.87% | 3.27% | -3.29% | -- |
| Other Financing Activities | -13.89% | 2.78% | 13.59% | -3.19% | -22.71% |
| Cash from Financing | 17.21% | 45.53% | -151.95% | 6.85% | 30.69% |
| Foreign Exchange rate Adjustments | 472.73% | -109.08% | 320.02% | 13.58% | 26.20% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 112.64% | -670.09% | -117.19% | 239.26% | 149.96% |
